• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction: Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?

作者信息

Dinçer Büşra Tetik, Usta Ayşe Merve, Kural Alev, Helvacı Nazlı, Uçar Ahmet, Urgancı Nafiye

机构信息

Department of Pediatrics, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

Department of Pediatrics, Division of Pediatric Gastroenterology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

出版信息

BMC Pediatr. 2025 Jan 8;25(1):16. doi: 10.1186/s12887-025-05392-3.

DOI:10.1186/s12887-025-05392-3
PMID:39780130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707946/
Abstract
摘要

相似文献

1
Correction: Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?更正：粪便钙卫蛋白能否用作肥胖青少年非酒精性脂肪性肝病的生物标志物？
BMC Pediatr. 2025 Jan 8;25(1):16. doi: 10.1186/s12887-025-05392-3.
2
Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?粪便钙卫蛋白能否作为肥胖青少年非酒精性脂肪性肝病的生物标志物？
BMC Pediatr. 2024 Dec 23;24(1):834. doi: 10.1186/s12887-024-05327-4.
3
Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children.肥胖和非酒精性脂肪性肝病与儿童粪便钙卫蛋白水平的相关性。
Arab J Gastroenterol. 2020 Dec;21(4):211-215. doi: 10.1016/j.ajg.2020.09.003. Epub 2020 Nov 25.
4
The fecal mycobiome in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的粪便真菌组。
J Hepatol. 2022 Apr;76(4):788-799. doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 10.
5
IS FECAL CALPROTECTIN DETERMINATION USEFUL FOR PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE?粪便钙卫蛋白检测对代谢相关脂肪性肝病患者是否有用？
Pol Merkur Lekarski. 2023;51(4):330-333. doi: 10.36740/Merkur202304105.
6
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.非肥胖非酒精性脂肪性肝病患者肝纤维化与肠道微生物组成的相关性。
J Gastroenterol Hepatol. 2021 Aug;36(8):2275-2284. doi: 10.1111/jgh.15487. Epub 2021 Mar 29.
7
Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.儿童和青少年肠易激综合征患者的体质量指数与粪便钙卫蛋白水平的相关性。
Medicine (Baltimore). 2022 Aug 12;101(32):e29968. doi: 10.1097/MD.0000000000029968.
8
Current status of fecal calprotectin as a diagnostic or monitoring biomarker for cow's milk protein allergy in children: a scoping review.儿童牛奶蛋白过敏症的粪便钙卫蛋白作为诊断或监测生物标志物的现状：范围综述。
World J Pediatr. 2021 Feb;17(1):63-70. doi: 10.1007/s12519-020-00364-2. Epub 2020 May 11.
9
Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population.血浆钙卫蛋白水平与普通人群疑似代谢相关脂肪性肝病及全因死亡率相关。
Int J Mol Sci. 2022 Dec 11;23(24):15708. doi: 10.3390/ijms232415708.
10
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial.粪便微生物移植治疗非酒精性脂肪性肝病的随机临床试验。
Front Cell Infect Microbiol. 2022 Jul 4;12:759306. doi: 10.3389/fcimb.2022.759306. eCollection 2022.

本文引用的文献

1
Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?粪便钙卫蛋白能否作为肥胖青少年非酒精性脂肪性肝病的生物标志物？
BMC Pediatr. 2024 Dec 23;24(1):834. doi: 10.1186/s12887-024-05327-4.